Overview

4.7 out of 5 (128 Reviews)

Credits

1.50

Post Assessment Questions

8

Start Date

1 Jan 2021

Last Review Date

22 Feb 2024

Expiration Date

31 Dec 2023

Estimated Time To Finish

90 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Apixaban is a novel oral anticoagulant approved by the US Food and Drug Administration (FDA) in 2012 for use in patients with nonvalvular atrial fibrillation to reduce the risk of stroke and blood clots. Later, in 2014, apixaban gained approval for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as for reducing the risk of blood clots (DVT and PE) in patients who have undergone knee or hip replacement surgery. The drug is also approved for reducing the risk of recurrent DVT and PE after initial therapy. 

This activity outlines the indications, mechanism of action, safe administration, adverse effects, contraindications, monitoring, overdose management, and toxicity of apixaban, thereby providing clinicians with a robust understanding of apixaban for treating various conditions and facilitating informed decision-making. This activity emphasizes that premature apixaban discontinuation heightens thrombotic event risks, necessitating consideration of alternative anticoagulants. By addressing these significant topics, this activity aims to enhance the proficiency and competence of healthcare professionals in managing apixaban therapy, thereby leading to improved patient outcomes.


Target Audience

This activity has been designed to meet the educational needs of physicians.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify appropriate indications for apixaban therapy across various clinical scenarios, including nonvalvular atrial fibrillation, deep vein thrombosis, pulmonary embolism, and post-surgical prophylaxis.

  • Implement evidence-based protocols for initiating, titrating, and monitoring apixaban therapy according to established guidelines and patient-specific factors.

  • Assess patients regularly for bleeding risk factors, adherence to apixaban therapy, and signs of adverse effects, ensuring timely intervention and adjustment of treatment plans when necessary.

  • Collaborate with other healthcare professionals to ensure seamless care coordination and continuity in apixaban therapy management based on patient characteristics, comorbidities, and preferences.

Disclosures

The Campbell University Jerry M. Wallace School of Osteopathic Medicine (CUSOM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they or their immediate family may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by CUSOM for resolution, to ensure fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

CUSOM will identify, review, and resolve all conflicts of interest that faculty, authors, activity directors, planners, managers, peer reviewers, or relevant staff disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. Disclosure information for authors, editors, planners, peer reviewers, and/or relevant staff is provided with this activity.

Continuing Education Accreditation Information

 

 

The Campbell University Jerry M. Wallace School of Osteopathic Medicine (CUSOM) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. CUSOM designates this enduring material for a maximum of 1.50 AOA Category 1 B Credits and will report CME credits commensurate with the extent of the physician's participation in the activity.

Cancellation Policy: Cancellations must be received in writing and a money back guarantee is provided if not completely satisfied.

  • StatPearls and CUSOM reserve the right to cancel any course due to unforeseen circumstances. StatPearls and CUSOM will not be responsible for other expenses incurred by the participant in the unlikely event that the program is canceled.

Equal Opportunity

  • StatPearls and CUSOM are Equal Opportunity / Affirmative Action / Equal Access Institutions. 

Medium or Media Used:

  • Computer Requirements:  Internet Access
  • E-mail Address

Instructions for Credit

  1. Register for the activity and create a StatPearls login.     
  2. Review the required accreditation information:  Target audience, learning objectives and disclosure information.
  3. Complete the entire self-study activity.
  4. Complete the post-test assessments.
  5. Successfully pass the post-test with a minimum score of 100%.
  6. Complete the evaluation form.
  7. Obtain a certificate.

StatPearls and CUSOM adheres to AOA Standards regarding commercial support of continuing medical education. It is the policy of StatPearls and Campbell that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved and also that authors and editors will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made prior to starting the activity.

The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

This course is intended for osteopathic physicians who wish to earn AOA CME credit. Take this version of the course to ensure you receive appropriate credit.

 

 
 

Reviews

Deborah Z. on 3/12/2021

John L. on 10/1/2021

Mirta A. on 10/18/2021

Theresa o. on 12/19/2021

amanda b. on 12/24/2021

Stephen M. on 12/28/2021

Kathleen H. on 2/4/2022

Melissa H. on 2/23/2022

Miranda H. on 3/29/2022

Zana L. on 4/15/2022

Paul H. on 5/8/2022

Brandy M. on 5/13/2022

Lauren S. on 5/19/2022

on 6/4/2022

Ejaz J. on 6/7/2022

Bridgette H. on 6/5/2022

Shanon Z. on 6/25/2022

Jennifer W. on 7/6/2022

Kari B. on 8/5/2022

Kathryn C. on 8/20/2022

Amanda F. on 9/12/2022

Candice P. on 9/19/2022

Brianna P. on 9/30/2022

gabrielle w. on 10/6/2022

jesse D. on 10/27/2022

Theodore B. on 11/6/2022

Janice R. on 11/12/2022

Charles W. on 11/12/2022

Robert M. on 11/14/2022

Ashley S. on 12/10/2022

Stephanie F. on 12/14/2022

Zahra T. on 12/17/2022

Allison A. on 12/19/2022

Kecia T. on 12/21/2022

Brian C. on 12/31/2022

Simranjit K. on 12/31/2022

Natalie p. on 1/4/2023

Scott O. on 1/8/2023

Deborah M. on 1/8/2023

Austin S. on 1/20/2023

STUART B. on 2/2/2023

Bashiru B. on 2/25/2023

Eric M. on 3/20/2023

Alexander D. on 3/28/2023

Sarah B. on 4/20/2023

Lily L. on 4/30/2023

Catherine S. on 5/5/2023

Noel J. on 5/10/2023

Daniela E. on 5/10/2023

john e. on 5/15/2023

JAMI W. on 5/31/2023

Jana T. on 6/1/2023

Michael L. on 6/2/2023

M A. on 6/15/2023

John H. on 6/24/2023

Corazon B. on 6/26/2023

Maili N. on 7/2/2023

MELISSA B. on 7/5/2023

Teddie H. on 7/14/2023

Sarah a. on 8/21/2023

Blessing O. on 8/28/2023

Lauren E. on 9/7/2023

Astasia G. on 9/16/2023

Michael K. on 9/9/2023

Abigail G. on 9/10/2023

shri v. on 9/18/2023

S s. on 9/18/2023

chris w. on 10/2/2023

Michelle G. on 9/24/2023

Thein A. on 9/25/2023

Michelle C. on 9/27/2023

roxanna g. on 10/4/2023

Dennis R. on 10/9/2023

Alannah C. on 10/12/2023

Mary D. on 10/27/2023

Kaitlin P. on 10/28/2023

Faith M. on 10/29/2023

Paul B. on 10/30/2023

michael s. on 11/2/2023

none

Angela D. on 11/2/2023

Andrew F. on 11/3/2023

Nizar N. on 11/5/2023

Bwayne M. on 11/7/2023

Carly S. on 11/8/2023

Denise W. on 11/9/2023

Susan H. on 11/11/2023

Ephron S. on 11/13/2023

Amardeep M. on 11/17/2023

Katherine H. on 11/22/2023

Andrea F. on 11/25/2023

Nicole W. on 11/28/2023

Mary M. on 12/1/2023

Nanette M. on 12/2/2023

Kimberly D. on 12/9/2023

alexandria g. on 12/9/2023

Michelle H. on 12/11/2023

Alessandro P. on 12/13/2023

Anne K. on 12/15/2023

Lee M. on 12/16/2023

Shayla J. on 12/17/2023

Chris V. on 12/25/2023

vasudha d. on 12/29/2023

Nitin M. on 12/31/2023

Lindsay W. on 1/4/2024

Courtney C. on 1/12/2024

CAROL G. on 1/12/2024

Brian B. on 1/13/2024

Emilye W. on 1/15/2024

James L. on 1/23/2024

Scott D. on 1/28/2024

Alexandra J. on 1/31/2024

bogdana t. on 2/3/2024

michael l. on 2/6/2024

Rebecca M. on 2/15/2024

Alon S. on 2/21/2024

Klaus M. on 2/27/2024

Mary K. on 2/27/2024

Phuong N. on 3/2/2024

Joseph F. on 3/12/2024

Charles S. on 3/14/2024

Leigh J. on 3/19/2024

Benjamin S. on 3/20/2024

Laura P. on 3/24/2024

Kristine S. on 3/27/2024

Luis R. on 3/31/2024

Nafea Z. on 4/4/2024

Stacy T. on 4/5/2024

Matthew J. on 4/11/2024

Unlimited Physician CME

Stay up to date on the latest medical knowledge with 6673 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7923.5 hours of CME.

Learn About Lifetime CME

Single Activity

Take this single activity

$39 1 activity

6 Month Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$399 per half year per user

1 Year Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$599 per 1 year per user